Johan Hansson
Overview
Explore the profile of Johan Hansson including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
198
Citations
8456
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Strehlenert H, Hansson J, Nystrom M, Hasson H
BMC Health Serv Res
. 2019 Oct;
19(1):730.
PMID: 31640680
Background: Comprehensive policies are becoming common for addressing wicked problems in health and social care. Success of these policies often varies between target organizations. This variation can often be attributed...
22.
Das I, Wilhelm M, Hoiom V, Franco Marquez R, Svedman F, Hansson J, et al.
Cell Death Dis
. 2019 Sep;
10(9):663.
PMID: 31506424
Current treatment modalities for disseminated cutaneous malignant melanoma (CMM) improve survival; however, relapses are common. A number of receptor tyrosine kinases (RTKs) including EGFR and MET have been reported to...
23.
Rad Pour S, Morikawa H, Kiani N, Yang M, Azimi A, Shafi G, et al.
Sci Rep
. 2019 Aug;
9(1):12150.
PMID: 31434983
Kynurenine pathway (KP) activation by the enzymatic activity of indoleamine 2,3-dioxygenase1 (IDO1) and kynurenine (KYN) production represents an attractive target for reducing tumour progression and improving anti-tumour immunity in multiple...
24.
Rozeman E, Menzies A, van Akkooi A, Adhikari C, Bierman C, van de Wiel B, et al.
Lancet Oncol
. 2019 Jun;
20(7):948-960.
PMID: 31160251
Background: The outcome of patients with macroscopic stage III melanoma is poor. Neoadjuvant treatment with ipilimumab plus nivolumab at the standard dosing schedule induced pathological responses in a high proportion...
25.
Taylor N, Mitra N, Qian L, Avril M, Bishop D, Bressac-de Paillerets B, et al.
J Am Acad Dermatol
. 2019 Feb;
81(2):386-394.
PMID: 30731170
Background: Although rare in the general population, highly penetrant germline mutations in CDKN2A are responsible for 5%-40% of melanoma cases reported in melanoma-prone families. We sought to determine whether MELPREDICT...
26.
Hansson J, Bartley K, Karagiannis T, Grob J, Kunstfeld R, Dreno B, et al.
Eur J Dermatol
. 2019 Jan;
28(6):775-783.
PMID: 30698147
Health-related quality of life (HRQoL) data are limited in patients with advanced basal cell carcinoma. To report HRQoL outcomes based on STEVIE (NCT01367665), a phase 2 study of vismodegib safety...
27.
Klarare A, Hansson J, Fossum B, Furst C, Hagelin C
J Interprof Care
. 2018 Nov;
33(5):504-511.
PMID: 30485125
To meet complex needs in persons and families within specialist palliative care, care team members are expected to work together in performing a comprehensive assessment of patient needs. Team type...
28.
Svedman F, Lohcharoenkal W, Bottai M, Egyhazi Brage S, Sonkoly E, Hansson J, et al.
PLoS One
. 2018 Nov;
13(11):e0206942.
PMID: 30399176
Background: Mitogen activated-protein kinase pathway inhibitors (MAPKis) improve treatment outcome in patients with disseminated BRAFV600 mutant cutaneous malignant melanoma (CMM) but responses are of limited duration due to emerging resistance....
29.
Klarare A, Rasmussen B, Fossum B, Hansson J, Furst C, Hagelin C
Eur J Cancer Care (Engl)
. 2018 Oct;
27(6):e12948.
PMID: 30298967
Patients with advanced cancer and family caregivers in palliative care face physical, psychological, social and existential challenges, much of the time home alone. Specialist palliative home care team services can...
30.
Thrane K, Eriksson H, Maaskola J, Hansson J, Lundeberg J
Cancer Res
. 2018 Aug;
78(20):5970-5979.
PMID: 30154148
Cutaneous malignant melanoma (melanoma) is characterized by a high mutational load, extensive intertumoral and intratumoral genetic heterogeneity, and complex tumor microenvironment (TME) interactions. Further insights into the mechanisms underlying melanoma...